Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham P Taylor

Showing results (21-30 of 227) with videos related to

Pageof 23
Sort By:
Current Hematologic Malignancy Reports|October 25, 2012
"Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL)Paul A Fields, Graham P Taylor
Expert Review of Anti-Infective Therapy|February 8, 2014
Antiretroviral therapy and preterm birth in HIV-infected womenCharlotte-Eve S Short, Graham P Taylor
Obstetrics and Gynecology|April 30, 2002
Hepatoxicity with antiretroviral treatment of pregnant womenGraham P Taylor, Eva Jungmann, Danielle Mercey
The Journal of Infectious Diseases|October 25, 2013
HTLV-1 and HTLV-2 prevalence in the United StatesLucy B M Cook, Graham P Taylor
Brain : a Journal of Neurology|July 17, 2023
Targeted immunotherapy for HTLV-1-associated myelopathy: a step in the right directionNicholas W S Davies, Graham P Taylor
Pathogens (Basel, Switzerland)|July 26, 2024
High HTLV-1 Proviral Load Predates and Predicts HTLV-1-Associated Disease: Literature Review and the London ExperienceGraham P Taylor, William Evans, Carolina Rosadas
Expert Review of Clinical Immunology|October 24, 2014
Inflammatory manifestations of HTLV-1 and their therapeutic optionsFabiola Martin, Graham P Taylor, Steven Jacobson
Frontiers in Medicine|March 3, 2022
Human T-Cell Lymphotropic Virus Type 1 and <i>Strongyloides stercoralis</i> Co-infection: A Systematic Review and Meta-AnalysisLingqing Ye, Graham P Taylor, Carolina Rosadas
Journal of Global Health|November 3, 2023
HTLV-1 as a contributing factor towards scabies and its systemic sequelaeBeatrice Cockbain, Carolina Rosadas, Graham P Taylor
The Lancet. Infectious Diseases|October 26, 2019
HTLV-1: the silent impact revealedLucy B M Cook, Graham P Taylor
Pageof 23

Showing results (21-30 of 227) with videos related to

Sort By:
Pageof 23
Current Hematologic Malignancy Reports|October 25, 2012
"Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL)Paul A Fields, Graham P Taylor
Expert Review of Anti-Infective Therapy|February 8, 2014
Antiretroviral therapy and preterm birth in HIV-infected womenCharlotte-Eve S Short, Graham P Taylor
Obstetrics and Gynecology|April 30, 2002
Hepatoxicity with antiretroviral treatment of pregnant womenGraham P Taylor, Eva Jungmann, Danielle Mercey
The Journal of Infectious Diseases|October 25, 2013
HTLV-1 and HTLV-2 prevalence in the United StatesLucy B M Cook, Graham P Taylor
Brain : a Journal of Neurology|July 17, 2023
Targeted immunotherapy for HTLV-1-associated myelopathy: a step in the right directionNicholas W S Davies, Graham P Taylor
Pathogens (Basel, Switzerland)|July 26, 2024
High HTLV-1 Proviral Load Predates and Predicts HTLV-1-Associated Disease: Literature Review and the London ExperienceGraham P Taylor, William Evans, Carolina Rosadas
Expert Review of Clinical Immunology|October 24, 2014
Inflammatory manifestations of HTLV-1 and their therapeutic optionsFabiola Martin, Graham P Taylor, Steven Jacobson
Frontiers in Medicine|March 3, 2022
Human T-Cell Lymphotropic Virus Type 1 and <i>Strongyloides stercoralis</i> Co-infection: A Systematic Review and Meta-AnalysisLingqing Ye, Graham P Taylor, Carolina Rosadas
Journal of Global Health|November 3, 2023
HTLV-1 as a contributing factor towards scabies and its systemic sequelaeBeatrice Cockbain, Carolina Rosadas, Graham P Taylor
The Lancet. Infectious Diseases|October 26, 2019
HTLV-1: the silent impact revealedLucy B M Cook, Graham P Taylor
Pageof 23